JNJ

168.17

-0.02%↓

NVS

117.18

-0.17%↓

ABT

128.48

+0.93%↑

TMO

477.65

-1.74%↓

ISRG

499.72

+0.13%↑

JNJ

168.17

-0.02%↓

NVS

117.18

-0.17%↓

ABT

128.48

+0.93%↑

TMO

477.65

-1.74%↓

ISRG

499.72

+0.13%↑

JNJ

168.17

-0.02%↓

NVS

117.18

-0.17%↓

ABT

128.48

+0.93%↑

TMO

477.65

-1.74%↓

ISRG

499.72

+0.13%↑

JNJ

168.17

-0.02%↓

NVS

117.18

-0.17%↓

ABT

128.48

+0.93%↑

TMO

477.65

-1.74%↓

ISRG

499.72

+0.13%↑

JNJ

168.17

-0.02%↓

NVS

117.18

-0.17%↓

ABT

128.48

+0.93%↑

TMO

477.65

-1.74%↓

ISRG

499.72

+0.13%↑

Search

MEDNAX Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

12.61 -0.63

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.45

Max

12.72

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-9.7M

21M

Pardavimai

-44M

458M

Pelno marža

4.524

Darbuotojai

4,120

EBITDA

-40M

9.6M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+20.99% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-23M

1.1B

Ankstesnė atidarymo kaina

13.24

Ankstesnė uždarymo kaina

12.61

Naujienos nuotaikos

By Acuity

50%

50%

157 / 375 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

MEDNAX Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-29 23:57; UTC

Įsigijimai, susijungimai, perėmimai

EQT: To Spend Y407.82B for Tender Offer

2025-07-29 23:56; UTC

Įsigijimai, susijungimai, perėmimai

EQT: Tender Offer Price Is Y5,700 a Share

2025-07-29 23:54; UTC

Įsigijimai, susijungimai, perėmimai

EQT To Start Tender Offer for Fujitec

2025-07-29 23:50; UTC

Rinkos pokalbiai

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

2025-07-29 23:36; UTC

Rinkos pokalbiai

Gold Steady Ahead of FOMC Decision -- Market Talk

2025-07-29 22:57; UTC

Rinkos pokalbiai

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

2025-07-29 22:50; UTC

Rinkos pokalbiai

Mondelez Warns of Price Increases in North America -- Market Talk

2025-07-29 22:44; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

2025-07-29 22:41; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

2025-07-29 22:41; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

2025-07-29 22:35; UTC

Uždarbis

IGO Maintains Nova Life of Mine Production Guidance

2025-07-29 22:35; UTC

Uždarbis

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

2025-07-29 22:35; UTC

Uždarbis

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

2025-07-29 22:34; UTC

Uždarbis

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

2025-07-29 22:34; UTC

Uždarbis

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

2025-07-29 22:34; UTC

Rinkos pokalbiai
Uždarbis

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

2025-07-29 22:33; UTC

Uždarbis

IGO Had A$279.7 Million of Cash at End-June

2025-07-29 22:33; UTC

Uždarbis

IGO 4Q Underlying Free Cash A$2.4 Million

2025-07-29 22:33; UTC

Uždarbis

IGO FY Sales Revenue A$512.5 Million

2025-07-29 22:33; UTC

Uždarbis

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

2025-07-29 22:32; UTC

Uždarbis

IGO FY Nickel Production 17,173 Tons

2025-07-29 22:32; UTC

Uždarbis

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

2025-07-29 22:32; UTC

Uždarbis

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

2025-07-29 22:31; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-07-29 22:31; UTC

Rinkos pokalbiai
Uždarbis

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

2025-07-29 22:31; UTC

Uždarbis

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

2025-07-29 22:31; UTC

Uždarbis

IGO FY Spodumene Production 1.48 Million Tons

2025-07-29 22:30; UTC

Uždarbis

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

2025-07-29 22:30; UTC

Uždarbis

IGO 4Q Underlying Ebitda A$62 Million

2025-07-29 22:22; UTC

Uždarbis

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Akcijų palyginimas

Kainos pokytis

MEDNAX Inc Prognozė

Kainos tikslas

By TipRanks

20.99% į viršų

12 mėnesių prognozė

Vidutinis 15.33 USD  20.99%

Aukščiausias 16 USD

Žemiausias 14 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines MEDNAX Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

1

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

12.945 / 14.48Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Neutral Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

157 / 375 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę MEDNAX Inc

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.